Hyong Kim Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 days, 16 hours ago
Hyong Kim has an estimated net worth of at least $11.6 million*, as of April 2, 2025. They own 509,367 shares of ALHC stock. They have sold 168,204 shares of ALHC stock since 2021, for an estimated $2.3 million.
Hyong Kim $ALHC SEC Form 4 Insider Trading
Hyong Kim has filed a total of 10 insider trades in $ALHC since 2021. Their most recent trade was a sale of 26,734 shares, made on Mar 20, 2025. Their largest trade was a sale of 62,574 shares, made on Dec 05, 2024. We estimate that they now own 509,367 shares of $ALHC, worth an estimated $9.3 million.
Insider Trading at $ALHC
There have been a total of 263 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 51.5 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 25,000 shares reported by CHRISTOPHER J JOYCE (Chief Legal and Admin. Officer), made on Apr 01, 2025.
History of Insider Stock Trades by Hyong Kim
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 26,734 | Mar 20, 2025 | March 21, 2025, 7:12 p.m. |
|
ALHC
|
Sale | 2,971 | Mar 19, 2025 | March 19, 2025, 9:50 p.m. |
|
ALHC
|
Sale | 5,295 | Mar 19, 2025 | March 19, 2025, 9:50 p.m. |
|
ALHC
|
Sale | 21,006 | Mar 07, 2025 | March 7, 2025, 7:37 p.m. |
|
ALHC
|
Sale | 568 | Mar 07, 2025 | March 7, 2025, 7:37 p.m. |
|
ALHC
|
Sale | 7,626 | Mar 06, 2025 | March 6, 2025, 8:31 p.m. |
|
ALHC
|
Sale | 13,394 | Mar 05, 2025 | March 6, 2025, 8:31 p.m. |
|
ALHC
|
Sale | 62,574 | Dec 05, 2024 | Dec. 6, 2024, 5:30 p.m. |
|
ALHC
|
Sale | 22,460 | Oct 08, 2024 | Oct. 10, 2024, 6:58 p.m. |
|
ALHC
|
Sale | 5,576 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
John E Kao, Chief Executive Officer
-
Dawn Christine Maroney, President, Markets
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Hakan Kardes, Chief Experience Officer
-
Dawn Christine Maroney, President
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.